🇺🇸
SAN DIEGO, Sept. 13, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) common stock between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”), have until tomorrow, Monday, September…
Source: prnewswire
Country: United States